Literature DB >> 20824035

New Therapeutic Options for Breast Cancer during Pregnancy.

Sibylle Loibl1.   

Abstract

National and international guidelines for pregnant breast cancer patients recommend to treat pregnant patients as closely as possible to the standards for non-pregnant patients. Therefore, new treatment options like sentinel lymph node biopsy or taxane-based chemotherapy have to be carefully checked for their possible implementation even for pregnant patients. These patients need to be treated in a breast cancer center where a multidisciplinary team is ready to support the patient and her family and to serve her with the best up-to-date treatment for mother and child.

Entities:  

Year:  2008        PMID: 20824035      PMCID: PMC2931113          DOI: 10.1159/000136002

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  54 in total

1.  The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up.

Authors:  Olga Vujovic; Anil Cherian; Edward Yu; A Rashid Dar; Larry Stitt; Francisco Perera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-01       Impact factor: 7.038

2.  Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.

Authors:  Alistair E Ring; Ian E Smith; Alison Jones; Catherine Shannon; Eleni Galani; Paul A Ellis
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

3.  Sentinel lymph node biopsy during pregnancy: initial clinical experience.

Authors:  Matthew M Mondi; Rosa E Cuenca; David W Ollila; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2006-10-25       Impact factor: 5.344

4.  Imaging of pregnancy-associated breast cancer.

Authors:  L Liberman; C S Giess; D D Dershaw; B M Deutch; J A Petrek
Journal:  Radiology       Date:  1994-04       Impact factor: 11.105

5.  Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

Authors:  Kathy D Miller; Linnea I Chap; Frankie A Holmes; Melody A Cobleigh; P Kelly Marcom; Louis Fehrenbacher; Maura Dickler; Beth A Overmoyer; James D Reimann; Amy P Sing; Virginia Langmuir; Hope S Rugo
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

6.  Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases.

Authors:  R I Mazze; B Källén
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

7.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

8.  The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.

Authors:  Adrienne Einarson; Caroline Maltepe; Yvette Navioz; Deborah Kennedy; Michael Paul Tan; Gideon Koren
Journal:  BJOG       Date:  2004-09       Impact factor: 6.531

9.  Trastuzumab use for metastatic breast cancer in pregnancy.

Authors:  Renuka Sekar; Peter R Stone
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

10.  Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Authors:  I Craig Henderson; Donald A Berry; George D Demetri; Constance T Cirrincione; Lori J Goldstein; Silvana Martino; James N Ingle; M Robert Cooper; Daniel F Hayes; Katherine H Tkaczuk; Gini Fleming; James F Holland; David B Duggan; John T Carpenter; Emil Frei; Richard L Schilsky; William C Wood; Hyman B Muss; Larry Norton
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

View more
  6 in total

1.  Breast Cancer in Special Situations.

Authors:  Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

2.  Being Pregnant and Diagnosed with Breast Cancer.

Authors:  Sibylle Loibl; Sileny N Han; Frederic Amant
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

3.  Breast Cancer during Pregnancy: An Interdisciplinary Approach in Our Institution.

Authors:  Cristina Pirvulescu; Christine Mau; Holger Schultz; Antje Sperfeld; Annette Isbruch; Heike Renner-Lützkendorf; Sybille Loibl; Ulrike Freitag; Gabriele Klühs; Barbara Fleige; Michael Untch
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

4.  Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature.

Authors:  Ingo Gottschalk; Christoph Berg; Nadia Harbeck; Rüdiger Stressig; Peter Kozlowski
Journal:  Breast Care (Basel)       Date:  2011-12-16       Impact factor: 2.860

5.  Association of the Timing of Pregnancy With Survival in Women With Breast Cancer.

Authors:  Javaid Iqbal; Eitan Amir; Paula A Rochon; Vasily Giannakeas; Ping Sun; Steven A Narod
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

Review 6.  Breast Cancer During Pregnancy.

Authors:  Sajid Durrani; Shomaila Akbar; Humariya Heena
Journal:  Cureus       Date:  2018-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.